Stock Screener App

Frei -

Installieren

26.20

4.09% 1.03

after-market

Handel nachbörslich: 26.22 0.02 +0.08%

Spyglass Pharma Inc (SGP)

Überblick Nachrichten Preisverlauf Forum Prognose

Spyglass Pharma Inc Aktie (SGP) Neueste Nachrichten

Spyglass Pharma (SGP) Insider Trading Activity 2026 $SGP - marketbeat.com

Spyglass Pharma (NASDAQ:SGP) Upgraded to "Moderate Buy" at Raymond James Financial - marketbeat.com

SpyGlass Pharma, Inc. (NASDAQ: SGP) Share Price, SGP Stock News, SGP Share Price & Updates - Kalkine

Raymond James initiates SpyGlass Pharma stock coverage with outperform rating - Investing.com

Q3 EPS Estimates for Spyglass Pharma Decreased by Analyst - marketbeat.com

SpyGlass Pharma Ord shs (Proposed) (SGP) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com

SpyGlass Pharma Reports Q2 Financials, Provides Corporate Updates - VisionMonday.com

Spyglass Pharma, Inc. (NASDAQ:SGP) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

SpyGlass Pharma 2Q 2026: Net loss $(19.9)M, EPS $(0.59) — 10-Q Summary - TradingView

[10-Q] SpyGlass Pharma, Inc. Quarterly Earnings Report - Stock Titan

SpyGlass Pharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

SpyGlass Pharma reports $19.9M Q2 net loss, $234.2M cash and investments as of June 30, 2026 - TradingView

SpyGlass Pharma Q2 net loss widens on higher expenses - TradingView

SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates - Yahoo Finance

SpyGlass Pharma Insiders Enjoying US$1.1m Appreciation On US$2.16m Investment - webull.com

SpyGlass Pharma (SGP) Rallies 3.08% to $24.41 as Ophthalmic Focus Draws Fresh BuyingLow Vol Factor - dars.gov.et

SpyGlass glaucoma trial enrollment remains on track for 2027 - Stock Titan

22,536,164 Common Stock of SpyGlass Pharma, Inc. are subject to a Lock-Up Agreement Ending on 5-AUG-2026. - marketscreener.com

SpyGlass Pharma (SGP) Gains 1.34% as Stock Tests Key Resistance LevelPoint of Control - dars.gov.et

SGP|SpyGlass Pharma Ord shs (Proposed)|Price:20.490|Chg%:-0.390 - TradingKey

Spyglass Pharma (NASDAQ:SGP) Shares Gap UpStill a Buy? - MarketBeat

SpyGlass Pharma, Inc. Revenue Breakdown – NASDAQ:SGP - TradingView

SpyGlass Pharma (SGP) Jefferies Global Healthcare Conference 2026 Summary - Quartr

Top Spyglass Pharma (SGP) Competitors 2026 - MarketBeat

SpyGlass Pharma (SGP) Drops 4.77% as Key Support Levels Are TestedFade Trade - dars.gov.et

SpyGlass Pharma (SGP) Dips Nearly 5%, Testing Key Support LevelsFundamentals - dars.gov.et

SpyGlass Pharma (SGP) Rallies 2.67%, Tests Key Resistance LevelDynamic Hedging - dars.gov.et

SGP Q1 2026 Earnings: EPS Misses Estimates as Revenue Remains AbsentEarnings Miss Alert - dars.gov.et

SpyGlass Pharma Inc. (SGP) Q1 2026 Earnings: Wider-Than-Expected Loss Triggers Double-Digit Selloff - dars.gov.et

SpyGlass Pharma (SGP) Slips 1.64% as Stock Tests Key Support Around $18.19Runaway Gap - po-news-eg.net

SGP Q1 2026 Earnings: EPS Misses Estimates, Stock Edges HigherLong-Term Guidance - dars.gov.et

SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to Russell 2000 Index - marketscreener.com

SpyGlass Pharma, Inc.(NasdaqGS:SGP) added to Russell Microcap Value Benchmark Index - marketscreener.com

SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to Russell 2000 Value Benchmark - marketscreener.com

SpyGlass Pharma (SGP) Registration Filing Summary - Quartr

SpyGlass Pharma, Inc.(NasdaqGS:SGP) added to Russell Microcap Growth Benchmark Index - marketscreener.com

SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to Russell 2000 Growth Benchmark - marketscreener.com

SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to Russell 3000E Growth Benchmark - marketscreener.com

SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to Russell Microcap Index - marketscreener.com

SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to Russell Small Cap Completeness Index - marketscreener.com

SGP Forecast — Price Target — Prediction for 2027 - TradingView

Transcript : SpyGlass Pharma, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-10-2026 10 - marketscreener.com

SpyGlass Pharma, Inc. Actuals & Estimates (NASDAQ:SGP) - TradingView

Price to sales forward of SpyGlass Pharma, Inc. – NASDAQ:SGP - TradingView

Enterprise value to revenue forward of SpyGlass Pharma, Inc. – NASDAQ:SGP - TradingView

Price to book forward of SpyGlass Pharma, Inc. – NASDAQ:SGP - TradingView

Price to earnings forward of SpyGlass Pharma, Inc. – NASDAQ:SGP - TradingView

Enterprise value to EBIT forward of SpyGlass Pharma, Inc. – NASDAQ:SGP - TradingView

Spyglass Pharma (SGP) Short Interest & Short Float | Updated Jun 2026 $SGP - MarketBeat

SpyGlass Pharma Inc. Q1 2026 Earnings: Wider-Than-Expected Loss Fails to Dampen Investor OptimismRevenue Miss Report - dars.gov.et

SpyGlass Pharma, Inc.(NasdaqGS: SGP) added to S&P Global BMI Index - marketscreener.com

SpyGlass Pharma Inc. (SGP) Rallies 2.75% as Stock Tests Key Resistance LevelsSell Signal Alerts - DonanımHaber

SpyGlass Pharma (SGP) Gains 2.75% as Shares Test Key Resistance LevelsMA Crossover - dars.gov.et

SpyGlass Taps Shannon Treviño as General Counsel - Orange County Business Journal

SpyGlass Pharma appoints Shannon Treviño as general counsel to support Phase 3 trials and commercialization plans. - Pluang

SpyGlass Pharma appoints Shannon Treviño as general counsel By Investing.com - Investing.com Nigeria

SpyGlass Pharma, Inc. Announces Appointment of Shannon Treviño to General Counsel - marketscreener.com

SpyGlass Pharma appoints Shannon Treviño as general counsel - Investing.com

SpyGlass Pharma Appoints Shannon Treviño as General Counsel - GlobeNewswire

MRNA

$63.32

0.52%

RPRX

$58.60

0.07%

ROIV

$36.20

0.22%

INSM

$123.74

2.05%

ALNY

$228.65

0.67%

ONC

$347.48

2.40%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters